Claus Kim Høgdall

Claus Kim Høgdall

Professor

Member of:

  • Obstetrics and Gynaecology


  1. 2016
  2. Published

    Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT)

    Schou Karlsen, N. M., Karlsen, M. A., Høgdall, Estrid Vilma Solyom, Nedergaard, L., Christensen, I. J. & Høgdall, Claus Kim, Jul 2016, In: Gynecologic Oncology. 142, 1, p. 50-3 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients

    Noer, M. C., Sperling, C. D., Antonsen, S. L., Ottesen, B., Christensen, I. J. & Høgdall, Claus Kim, Jun 2016, In: Gynecologic Oncology. 141, 3, p. 471-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Does stage of cancer, comorbidity or lifestyle factors explain educational differences in survival after endometrial cancer? A cohort study among Danish women diagnosed 2005-2009

    Seidelin, U. H., Ibfelt, E., Andersen, Ingelise, Steding-Jessen, M., Høgdall, Claus Kim, Kjær, Susanne Krüger & Dalton, S. O., Jun 2016, In: Acta Oncologica. 55, 6, p. 680-685 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012

    Edwards, H. M., Noer, M. C., Sperling, C. D., Nguyen-Nielsen, M., Lundvall, L., Christensen, I. J. & Høgdall, Claus Kim, Jun 2016, In: Acta Oncologica. 55 , S2, p. 36-43 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Current status on microRNAs as biomarkers for ovarian cancer

    Prahm, K. P., Novotny, G. W., Høgdall, Claus Kim & Høgdall, Estrid Vilma Solyom, May 2016, In: APMIS - Journal of Pathology, Microbiology and Immunology. 124, 5, p. 337-55 19 p.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

    Hollestelle, A., van der Baan, F. H., Berchuck, A., Johnatty, S. E., Aben, K. K., Agnarsson, B. A., Aittomäki, K., Alducci, E., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Antoniou, A. C., Apicella, C., Arndt, V., Arnold, N., Arun, B. K., Arver, B., Ashworth, A., Baglietto, L., Balleine, R. & 31 others, Bandera, E. V., Barrowdale, D., Bean, Y. T., Beckmann, L., Beckmann, M. W., Benitez, J., Berger, A., Berger, R., Beuselinck, B., Bisogna, M., Bjorge, L., Blomqvist, C., Bogdanova, N. V., Bojesen, A., Bojesen, Stig Egil, Bolla, M. K., Bonanni, B., Brand, J. S., Brauch, H., Brenner, H., Brinton, L., Brooks-Wilson, A., Bruinsma, F., Brunet, J., Gerdes, Anne-Marie Axø, Høgdall, Claus Kim, Høgdall, Estrid Vilma Solyom, Kjær, Susanne Krüger, Nielsen, Finn Cilius, Nordestgaard, Børge & Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, O. C. A. C. B. C. A. C. A. C. O. M. O. B. A. B., May 2016, In: Gynecologic Oncology. 141, 2, p. 386–401

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

    Rosendahl, M., Høgdall, Claus Kim & Mosgaard, B. J., May 2016, In: International Journal of Gynecological Cancer. 26, 4, p. 680-687 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology—A Comparative Study

    Schnack, T. H., Høgdall, Estrid Vilma Solyom, Nedergaard, L. & Høgdall, Claus Kim, Jan 2016, In: International Journal of Gynecological Cancer. 26, 1, p. 82-90 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

    Hampras, S. S., Sucheston-Campbell, L. E., Cannioto, R., Chang-Claude, J., Modugno, F., Doerk, T., Hillemanns, P., Preus, L., Knutson, K. L., Wallace, P. K., Hong, C., Friel, G., Davis, W., Nesline, M., Pearce, C. L., Kelemen, L. E., Goodman, M. T., Bandera, E. V., Terry, K. L., Schoof, N. & 150 others, Eng, K. H., Clay, A. I., Singh, P. K., Joseph, J. M., Aben, K. K. H., Anton-Culver, H., Antonenkova, N., Baker, H., Bean, Y., Beckmann, M. W., Bisogna, M., Bjorge, L., Bogdanova, N., Brinton, L. A., Brooks-Wilson, A., Bruinsma, F., Butzow, R., Campbell, I. G., Carty, K., Cook, L. S., Cramer, D. W., Cybulski, C., Dansonka-Mieszkowska, A., Dennis, J., Despierre, E., Dicks, E., Doherty, J. A., Du Bois, A., Durst, M., Easton, D., Eccles, D., Edwards, R. P., Ekici, A. B., Fasching, P. A., Fridley, B. L., Gao, Y., Gentry-Maharaj, A., Giles, G., Glasspool, R. M., Gronwald, J., Harrington, P., Harter, P., Hasmad, H. N., Hein, A., Heitz, F., Hildebrandt, M. A. T., Høgdall, Claus Kim, Hogdall, E., Hosono, S., Iversen, E. S., Jakubowska, A., Jensen, A., Ji, B., Karlan, B. Y., Kellar, M., Kelley, J. L., Kiemeney, L. A., Klapdor, R., Kolomeyevskaya, N., Krakstad, C., Kjær, Susanne Krüger, Kruszka, B., Kupryjanczyk, J., Lambrechts, D., Lambrechts, S., Le, N. D., Lee, A. W., Lele, S., Leminen, A., Lester, J., Levine, D. A., Liang, D., Lissowska, J., Liu, S., Lu, K., Lubinski, J., Lundvall, L., Massuger, L. F. A. G., Matsuo, K., McGuire, V., McLaughlin, J. R., McNeish, I., Menon, U., Moes-Sosnowska, J., Narod, S. A., Nedergaard, L., Nevanlinna, H., Nickels, S., Olson, S. H., Orlow, I., Weber, R. P., Paul, J., Pejovic, T., Pelttari, L. M., Perkins, B., Permuth-Wey, J., Pike, M. C., Plisiecka-Halasa, J., Poole, E. M., Risch, H. A., Rossing, M. A., Rothstein, J. H., Rudolph, A., Runnebaum, I. B., Rzepecka, I. K., Salvesen, H. B., Schernhammer, E., Schmitt, K., Schwaab, I., Shu, X., Shvetsov, Y. B., Siddiqui, N., Sieh, W., Song, H., Southey, M. C., Tangen, I. L., Teo, S., Thompson, P. J., Timorek, A., Tsai, Y., Tworoger, S. S., Tyrer, J., van Altena, A. M., Vergote, I., Vierkant, R. A., Walsh, C., Wang-Gohrke, S., Wentzensen, N., Whittemore, A. S., Wicklund, K. G., Wilkens, L. R., Wu, A. H., Wu, X., Woo, Y. L., Yang, H., Zheng, W., Ziogas, A., Gayther, S. A., Ramus, S. J., Sellers, T. A., Schildkraut, J. M., Phelan, C. M., Berchuck, A., Chenevix-Trench, G., Cunningham, J. M., Pharoah, P., Ness, R. B., Odunsi, K., Goode, E. L. & Moysich, K. B., 2016, In: OncoTarget. 7, 43, p. 69097-69110 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

    Meeks, H. D., Song, H., Michailidou, K., Bolla, M. K., Dennis, J., Wang, Q., Barrowdale, D., Frost, D., McGuffog, L., Ellis, S., Feng, B., Buys, S. S., Hopper, J. L., Southey, M. C., Tesoriero, A., James, P. A., Bruinsma, F., Campbell, I. G., Broeks, A., Schmidt, M. K. & 31 others, Hogervorst, F. B. L., Beckman, M. W., Fasching, P. A., Fletcher, O., Johnson, N., Sawyer, E. J., Riboli, E., Banerjee, S., Menon, U., Tomlinson, I., Burwinkel, B., Hamann, U., Marme, F., Rudolph, A., Janavicius, R., Tihomirova, L., Tung, N., Garber, J., Cramer, D., Terry, K. L., Poole, E. M., Tworoger, S. S., Dorfling, C. M., van Rensburg, E. J., Godwin, A. K., Bojesen, Stig Egil, Gerdes, Anne-Marie Axø, Kjær, Susanne Krüger, Høgdall, Claus Kim, Høgdall, Estrid Vilma Solyom & EMBRACE, E., 2016, In: JNCI - Journal of the National Cancer Institute. 108, 2, 10 p., djv315.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 983775